Thursday - April 23, 2026
GSK Presents New Data at the Alzheimer's Association International Conference 2024
July 31, 2024
LONDON, England, July 31 -- GSK (formerly GlaxoSmithKline), a biopharmaceutical company, issued the following news release on July 30, 2024:

* * *

- ZOSTER-122 retrospective study presented during Featured Research Session on shingles and dementia risk

- Retrospective study observed statistically significant association between Shingrix vaccination and reduction of dementia risk, compared to Zostavax and Pneumovax 23, with further studies planned

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products